On the public citation graph
Treatment of corneal cystine crystal accumulation in patients with cystinosis
0 signed · 119 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archopht.118.10.1329openalex-snapshot
Ultrasound Biomicroscopy of the Eye in Cystinosis
inferredcites →https://doi.org/10.1001/archopht.120.12.1742openalex-snapshot
In Vivo Confocal Microscopy of the Cornea in Nephropathic Cystinosis
inferredcites →https://doi.org/10.1001/archopht.1967.00980020363014openalex-snapshot
Alterations of Pigment Epithelium in Cystinosis
inferredcites →https://doi.org/10.1001/archopht.1986.01050170096030openalex-snapshot
Long-term Ocular Manifestations in Nephropathic Cystinosis
inferredcites →https://doi.org/10.1001/archopht.1990.01070070075038openalex-snapshot
A Randomized Placebo-Controlled Trial of Cysteamine Eye Drops in Nephropathic Cystinosis
inferredcites →https://doi.org/10.1001/jama.1957.02980040034009openalex-snapshot
CYSTINOSIS IN AN ADULT
inferredcites →https://doi.org/10.1001/jama.1993.03510180070036openalex-snapshot
Classic Nephropathic Cystinosis as an Adult Disease
inferredcites →https://doi.org/10.1002/humu.10141openalex-snapshot
Identification of 14 novelCTNS mutations and characterization of seven splice site mutations associated with cystinosis
inferredcites →https://doi.org/10.1006/mgme.1998.2725openalex-snapshot
A Randomized Clinical Trial of Topical Cysteamine Disulfide (Cystamine) versus Free Thiol (Cysteamine) in the Treatment of Corneal Cystine Crystals in Cystinosis
inferredcites →https://doi.org/10.1006/mgme.2000.3062openalex-snapshot
Corneal Crystals in Nephropathic Cystinosis: Natural History and Treatment with Cysteamine Eyedrops
inferredcites →https://doi.org/10.1006/mgme.2001.3218openalex-snapshot
CTNS Mutations in African American Patients with Cystinosis
inferredcites →https://doi.org/10.1007/bf00856532openalex-snapshot
Progression of chronic renal failure in a historical group of patients with nephropathic cystinosis
inferredcites →https://doi.org/10.1007/s001090050220openalex-snapshot
Clinical and molecular aspects of nephropathic cystinosis
inferredcites →https://doi.org/10.1007/s00467-007-0650-8openalex-snapshot
Nephropathic cystinosis: late complications of a multisystemic disease
inferredcites →https://doi.org/10.1016/0002-9343(62)90221-8openalex-snapshot
The Fanconi syndrome with cystinosis
inferredcites →https://doi.org/10.1016/0002-9394(86)90773-7openalex-snapshot
Pupillary-Block Glaucoma Associated with Childhood Cystinosis
inferredcites →https://doi.org/10.1016/0002-9394(87)90018-3openalex-snapshot
Recurrent Crystal Deposition After Keratoplasty in Nephropathic Cystinosis
inferredcites →https://doi.org/10.1016/0039-6257(82)90124-2openalex-snapshot
Metabolic tapetoretinal degenerations
inferredcites →https://doi.org/10.1016/j.ejpb.2013.04.017openalex-snapshot
Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lenses
inferredcites →https://doi.org/10.1016/j.survophthal.2006.10.006openalex-snapshot
Ophthalmic Manifestations and Histopathology of Infantile Nephropathic Cystinosis: Report of a Case and Review of the Literature
inferredcites →https://doi.org/10.1016/j.ymgme.2013.12.298openalex-snapshot
A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: The Cystadrops OCT-1 study
inferredcites →https://doi.org/10.1016/s0021-9258(18)89141-4openalex-snapshot
Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. Role in therapeutic cystine removal?
inferredcites →https://doi.org/10.1016/s0022-3476(86)80221-9openalex-snapshot
Course of nephropathic cystinosis after age 10 years
inferredcites →https://doi.org/10.1038/eye.1991.139openalex-snapshot
A randomised placebo-controlled trial of topical cysteamine therapy in patients with nephropathic cystinosis
inferredcites →https://doi.org/10.1038/ki.1995.324openalex-snapshot
Renal proximal tubular epithelium from patients with nephropathic cystinosis: Immortalized cell lines as in vitro model systems
inferredcites →https://doi.org/10.1038/ki.2011.277openalex-snapshot
Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults
inferredcites →https://doi.org/10.1038/ki.2011.301openalex-snapshot
Cysteamine therapy: a treatment for cystinosis, not a cure
inferredcites →https://doi.org/10.1038/ng0498-319openalex-snapshot
A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis
inferredcites →https://doi.org/10.1073/pnas.1211198109openalex-snapshot
Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy
inferredcites →https://doi.org/10.1086/302118openalex-snapshot
CTNS Mutations in an American-Based Population of Cystinosis Patients
inferredcites →https://doi.org/10.1093/emboj/20.21.5940openalex-snapshot
Cystinosin, the protein defective in cystinosis, is a H+‐driven lysosomal cystine transporter
inferredcites →https://doi.org/10.1093/hmg/8.13.2507openalex-snapshot
Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin
inferredcites →https://doi.org/10.1093/ndt/gfp553openalex-snapshot
Renal phenotype of the cystinosis mouse model is dependent upon genetic background
inferredcites →https://doi.org/10.1097/00003226-200203000-00009openalex-snapshot
Age-Related Prevalence of Anterior Segment Complications in Patients With Infantile Nephropathic Cystinosis
inferredcites →https://doi.org/10.1097/00006982-198200230-00018openalex-snapshot
Metabolic Tapetoretinal Degenerations
inferredcites →https://doi.org/10.1097/01.asn.0000036867.49866.59openalex-snapshot
Lysosomal Cystine Storage Augments Apoptosis in Cultured Human Fibroblasts and Renal Tubular Epithelial Cells
inferredcites →https://doi.org/10.1111/j.1442-9071.2007.01467.xopenalex-snapshot
In vivo confocal microscopy and polarizing microscopy of the cornea in a patient with nephropathic cystinosis
inferredcites →https://doi.org/10.1128/mcb.22.21.7622-7632.2002openalex-snapshot
Intralysosomal Cystine Accumulation in Mice Lacking Cystinosin, the Protein Defective in Cystinosis
inferredcites →https://doi.org/10.1136/bjo.2005.074468openalex-snapshot
Confocal microscopy of the cornea in nephropathic cystinosis
inferredcites →https://doi.org/10.1136/bjo.73.8.665openalex-snapshot
Corneal thickness in nephropathic cystinosis.
inferredcites →https://doi.org/10.1136/bjo.75.5.311openalex-snapshot
Clearance of corneal crystals in nephropathic cystinosis by topical cysteamine 0.5%.
inferredcites →https://doi.org/10.1136/bjo.87.1.28openalex-snapshot
A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis
inferredcites →https://doi.org/10.1146/annurev.genom.2.1.69openalex-snapshot
Human Genetics: Lessons from Quebec Populations
inferredcites →https://doi.org/10.1159/000299940openalex-snapshot
Ueber die Cystinkrankheit im Kleinkindesalter unter besonderer Berücksichtigung des Augenbefundes
inferredcites →https://doi.org/10.1159/000305884openalex-snapshot
Ocular Manifestations of Cystinosis
inferredcites →https://doi.org/10.1159/000309288openalex-snapshot
Netzhautveränderungen bei Zystinose
inferredcites →https://doi.org/10.1172/jci108448openalex-snapshot
Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo.
inferredcites →https://doi.org/10.1172/jci115103openalex-snapshot
Role of adenosine triphosphate (ATP) and NaK ATPase in the inhibition of proximal tubule transport with intracellular cystine loading.
inferredcites →https://doi.org/10.1182/blood-2009-03-213934openalex-snapshot
Successful treatment of the murine model of cystinosis using bone marrow cell transplantation
inferredcites →https://doi.org/10.1203/00006450-200001000-00007openalex-snapshot
Ocular Nonnephropathic Cystinosis: Clinical, Biochemical, and Molecular Correlations
inferredcites →https://doi.org/10.1203/01.pdr.0000196334.46940.54openalex-snapshot
Decreased Intracellular ATP Content and Intact Mitochondrial Energy Generating Capacity in Human Cystinotic Fibroblasts
inferredcites →https://doi.org/10.1210/jc.80.11.3257openalex-snapshot
Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis
inferredcites →https://doi.org/10.1371/journal.pone.0042840openalex-snapshot
Stem Cell Microvesicles Transfer Cystinosin to Human Cystinotic Cells and Reduce Cystine Accumulation In Vitro
inferredcites →https://doi.org/10.1515/bchm2.1903.38.5-6.557openalex-snapshot
Familiäre Cystindiathese.
inferredcites →https://doi.org/10.3109/13816818709028529openalex-snapshot
Ocular changes in long-term evolution of infantile cystinosis
inferredcites →https://doi.org/10.3928/0191-3913-19790101-06openalex-snapshot
Long-Term Ocular Changes in Cystinosis: Observations in Renal Transplant Recipients
inferredcites →https://doi.org/10.3928/0191-3913-19900901-14openalex-snapshot
The Effect of Topical Cysteamine Drops on Reducing Crystal Formation Within the Cornea of Patients Affected by Nephropathic Cystinosis
inferredcites →https://doi.org/10.3928/0191-3913-19940701-18openalex-snapshot
Recurrent Corneal Erosion in Cystinosis
inferredcites →https://doi.org/10.7326/0003-4819-109-7-557openalex-snapshot
Cystinosis: Progress in a Prototypic Disease
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/ange.202010530openalex-snapshot
An Innovative Hydrogen Peroxide‐Sensing Scaffold and Insight Towards its Potential as an ROS‐Activated Persulfide Donor
inferred← citeshttps://doi.org/10.1002/anie.202010530openalex-snapshot
An Innovative Hydrogen Peroxide‐Sensing Scaffold and Insight Towards its Potential as an ROS‐Activated Persulfide Donor
inferred← citeshttps://doi.org/10.1002/chem.201904133openalex-snapshot
Selenosulfides Tethered to gem ‐Dimethyl Esters: A Robust and Highly Versatile Framework for H 2 S Probe Development
inferred← citeshttps://doi.org/10.1002/jppr.1148openalex-snapshot
Cysteamine eye drops in the treatment of cystinosis – an Australian perspective
inferred← citeshttps://doi.org/10.1007/s00347-016-0269-xopenalex-snapshot
Bilaterale kristalline Einlagerungen im Hornhautstroma
inferred← citeshttps://doi.org/10.1007/s40123-017-0089-3openalex-snapshot
Clinical Practice: A Proposed Standardized Ophthalmological Assessment for Patients with Cystinosis
inferred← citeshttps://doi.org/10.1007/s40123-018-0146-6openalex-snapshot
Latest Clinical Approaches in the Ocular Management of Cystinosis: A Review of Current Practice and Opinion from the Ophthalmology Cystinosis Forum
inferred← citeshttps://doi.org/10.1007/s40123-018-0156-4openalex-snapshot
The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series
inferred← citeshttps://doi.org/10.1007/s40123-025-01170-7openalex-snapshot
The Use of a Viscous Cysteamine Eyedrop in a Belgian Cohort: Early 3-Year Results
inferred← citeshttps://doi.org/10.1007/s40124-026-00392-yopenalex-snapshot
An Update on Nephropathic Cystinosis for the General Pediatrician
inferred← citeshttps://doi.org/10.1007/s40267-017-0398-6openalex-snapshot
Cystadrops® (cysteamine hydrochloride 0.55% viscous eye-drops solution) in treating corneal cystine crystal deposits in patients with cystinosis: a profile of its use
inferred← citeshttps://doi.org/10.1007/s44162-024-00053-yopenalex-snapshot
Intermediate type cystinosis with a novel CTNS variant in a child: a case report
inferred← citeshttps://doi.org/10.1016/b978-0-7020-6616-0.00034-7openalex-snapshot
Corneal abnormalities in childhood
inferred← citeshttps://doi.org/10.1016/b978-0-7020-6616-0.00094-3openalex-snapshot
“My child seems to hate the bright light”
inferred← citeshttps://doi.org/10.1016/j.ajo.2026.01.038openalex-snapshot
Comprehensive Ocular Characteristics in Cystinosis after Hematopoietic Stem-Cell Gene Therapy Over 24 Months
inferred← citeshttps://doi.org/10.1016/j.colsurfa.2018.11.031openalex-snapshot
In vitro and ex vivo implantation of cystine crystals and treatment by contact lens
inferred← citeshttps://doi.org/10.1016/j.ejpb.2016.07.009openalex-snapshot
Effect of pH and penetration enhancers on cysteamine stability and trans-corneal transport
inferred← citeshttps://doi.org/10.1016/j.exer.2021.108455openalex-snapshot
Systemic diseases and the cornea
inferred← citeshttps://doi.org/10.1016/j.exer.2022.109338openalex-snapshot
The TGM2 Inhibitor Cysteamine Hydrochloride Does Not Impact Corneal Epithelial and Stromal Wound Healing in Vitro and in Vivo
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2017.06.060openalex-snapshot
Cysteamine polysaccharide hydrogels: Study of extended ocular delivery and biopermanence time by PET imaging
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2018.09.021openalex-snapshot
Potential role of stromal collagen in cystine crystallization in cystinosis patients
inferred← citeshttps://doi.org/10.1016/j.jtos.2023.06.002openalex-snapshot
The gene therapy for corneal pathology with novel nonsense cystinosis mouse lines created by CRISPR Gene Editing
inferred← citeshttps://doi.org/10.1016/j.microc.2024.110319openalex-snapshot
Two dimensional solvothermal synthesis via ultrasound (2D-STSUS) of fluorescent tungsten-doped hBN nanosheets for the selective detection of cancer markers
inferred← citeshttps://doi.org/10.1016/j.nefro.2016.11.024openalex-snapshot
CTNS molecular genetics profile in a Persian nephropathic cystinosis population
inferred← citeshttps://doi.org/10.1016/j.nefroe.2017.02.007openalex-snapshot
CTNS molecular genetics profile in a Persian nephropathic cystinosis population
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.6b00488openalex-snapshot
Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis
inferred← citeshttps://doi.org/10.1055/a-2020-0926openalex-snapshot
Corneal Manifestation in Patients with Infantile Nephropathic Cystinosis
inferred← citeshttps://doi.org/10.1080/13816810.2023.2253901openalex-snapshot
Ocular manifestations of the genetic renal tubulopathies
inferred← citeshttps://doi.org/10.1093/hmg/ddac033openalex-snapshot
Multisystem involvement, defective lysosomes and impaired autophagy in a novel rat model of nephropathic cystinosis
inferred← citeshttps://doi.org/10.1111/ceo.12790openalex-snapshot
Systemic associations of corneal deposits: a review and photographic guide
inferred← citeshttps://doi.org/10.1136/bjophthalmol-2016-309278openalex-snapshot
Efficacy of topical cysteamine in nephropathic cystinosis
inferred← citeshttps://doi.org/10.1136/bjophthalmol-2020-316450openalex-snapshot
Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride
inferred← citeshttps://doi.org/10.1167/iovs.16-21080openalex-snapshot
A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study
inferred← citeshttps://doi.org/10.1177/1093526616683873openalex-snapshot
Value of Renal Biopsy in Diagnosing Infantile Nephropathic Cystinosis Associated With Secondary Nephrogenic Diabetes Insipidus
inferred← citeshttps://doi.org/10.1177/1120672119848899openalex-snapshot
Ocular manifestations of intermediate cystinosis: To treat or not to treat?
inferred← citeshttps://doi.org/10.1186/s12886-020-01336-wopenalex-snapshot
Examination of corneal deposits in nephropathic cystinosis using in vivo confocal microscopy and anterior segment optical coherence tomography: an age-dependent cross sectional study
inferred← citeshttps://doi.org/10.12659/ajcr.916737openalex-snapshot
Asymmetrical Ocular Manifestations of Nephropathic Cystinosis; A Case Report
inferred← citeshttps://doi.org/10.2147/opth.s133516openalex-snapshot
Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review
inferred← citeshttps://doi.org/10.2147/opth.s479770openalex-snapshot
An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients
inferred← citeshttps://doi.org/10.33140/mcr.08.03.02openalex-snapshot
Cystinosis in a routine ophthalmologic evaluation
inferred← citeshttps://doi.org/10.33590/emjnephrol/10312504openalex-snapshot
Ophthalmology Cystinosis Forum Morning Session
inferred← citeshttps://doi.org/10.3389/fped.2018.00058openalex-snapshot
Nephropathic Cystinosis: Symptoms, Treatment, and Perspectives of a Systemic Disease
inferred← citeshttps://doi.org/10.3389/fphar.2025.1599816openalex-snapshot
Synthetic and semi-synthetic antioxidants in medicine and food industry: a review
inferred← citeshttps://doi.org/10.3390/diagnostics10110911openalex-snapshot
Ophthalmic Evaluation of Diagnosed Cases of Eye Cystinosis: A Tertiary Care Center’s Experience
inferred← citeshttps://doi.org/10.3390/ijms24021253openalex-snapshot
The Pitfall of White Blood Cell Cystine Measurement to Diagnose Juvenile Cystinosis
inferred← citeshttps://doi.org/10.3390/ijms25031623openalex-snapshot
A Comparative Pharmacokinetic Study for Cysteamine-Containing Eye Drops as an Orphan Topical Therapy in Cystinosis
inferred← citeshttps://doi.org/10.3390/ph15010002openalex-snapshot
Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations
inferred← citeshttps://doi.org/10.3390/pharmaceutics12121177openalex-snapshot
Recent Research in Ocular Cystinosis: Drug Delivery Systems, Cysteamine Detection Methods and Future Perspectives
inferred← citeshttps://doi.org/10.3390/pharmaceutics16081052openalex-snapshot
Development and Evaluation of Different Electrospun Cysteamine-Loaded Nanofibrous Webs: A Promising Option for Treating a Rare Lysosomal Storage Disorder
inferred← citeshttps://doi.org/10.3928/01913913-20241001-02openalex-snapshot
Ocular Cystinosis Experience in Southwestern Ontario
inferred← citeshttps://doi.org/10.4103/ajpn.ajpn_8_20openalex-snapshot
Nephropathic cystinosis: A cause of renal fanconi syndrome
inferred← citeshttps://doi.org/10.4103/ijo.ijo_2418_21openalex-snapshot
Importance of adherence to topical cysteamine in infantile ocular cystinosis: An illustrative case
inferred← citeshttps://doi.org/10.5802/crchim.135openalex-snapshot
Cystinuria and cystinosis are usually related to L-cystine: is this really the case for cystinosis? A physicochemical investigation at micrometre and nanometre scale
inferred← citeshttps://doi.org/10.70675/458483cezbec6z4277zb67dz629203c5debaopenalex-snapshot
Glycovecteurs pour le ciblage thérapeutique d'une maladie rare lysosomale : la maladie de Pompe
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.